Limitations of the current study include the overrepresentation of participants diagnosed with a hematologic cancer. Recruitment was initially through convenience sampling and, despite the later use of purposive sampling to balance the distribution of diagnoses, a greater number of participants with hematologic cancers appear to be included in the researchers’ sample.